RT Journal Article SR Electronic T1 Predictors for high ventricular arrhythmia burden in patients with heart failure with reduced ejection fraction and central sleep apnea: an analysis of the SERVE-HF major substudy JF ERJ Open Research JO erjor FD European Respiratory Society SP 14 DO 10.1183/23120541.sleepandbreathing-2021.14 VO 7 IS suppl 7 A1 C Fisser A1 J Bureck A1 L Gall A1 V Vaas A1 J Priefert A1 S Fredersdorf A1 F Zeman A1 D Linz A1 H Wöhrle A1 R Tamisier A1 H Teschler A1 M Cowie A1 M Arzt YR 2021 UL http://openres.ersjournals.com/content/7/suppl_7/14.abstract AB Aim: Central sleep apnea (CSA) and Cheyne-Stokes respiration (CSR) are associated with increased mortality rates in patients with heart failure and reduced ejection fraction (HFrEF) and may trigger ventricular arrhythmias. Therefore, we investigated predictors of ventricular arrhythmias in HFrEF patients with CSA.Methods: 239 patients with HFrEF and CSA (apnea-hypopnea index >15/h with ≥50% central events) of the SERVE-HF major substudy with available polysomnography including nocturnal ECG were analyzed. CSR was quantified in ≥20% and <20% of total recording time. High ventricular arrhythmia burden was defined as >30 premature ventricular contractions (PVCs) per hour of sleep. A subanalysis was performed to evaluate the temporal association of CSR with ventricular arrhythmias in sleep stage N2 (55 hours).Results: High ventricular arrhythmia burden was observed in 44% of the sample. In multivariate regression analysis, male sex, lower systolic blood pressure, antiarrhythmics and CSR≥20% were associated with PVC>30/hour (odds ratio [95%CI]: 5.49 [1.51;19.91], p=0.010; 0.98 [0.97;1.00], p=0.017; 0.20 [0.08;0.52], p=0.001; 2.22 [1.22;4.05]; p=0.009; respectively). PVCs were more frequent in sleep phases with CSR than without CSR (median [IQR]: 64.6 [24.8; 145.7] vs. 34.6 [4.8; 75.2] per hour N2 sleep; p=0.006).Conclusion: High burden of ventricular arrhythmias occurred in 44% of patients with HFrEF and CSA. Risk factors for PVCs>30/hour were male sex, lower systolic blood pressure, antiarrhythmic medication and CSR≥20%. Ventricular arrhythmia burden was higher during sleep with CSR than without CSR.FootnotesCite this article as ERJ Open Research 2021; 7: Suppl. 7, 14.This is an ERS Lung Science Conference abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).